Nexstep Medical

Nexstep Medical specializes in peripheral angioplasty balloon catheters, specifically designed for percutaneous transluminal angioplasty (PTA). These devices are used to mechanically widen narrowed or obstructed blood vessels in peripheral arteries, helping restore blood flow in vascular conditions. The primary product line includes the All'InCath 035M PTA Balloon Dilatation Catheter, which falls under this category.

Nexstep Medical is based in the United States. Since the company operates within the U.S., its devices are subject to FDA regulatory oversight. The FDA classifies these devices as Class II, which means they are considered to have an acceptable level of risk and require premarket notification (510(k)) clearance before being marketed. This classification ensures that the devices meet specific performance standards and safety requirements.

Nexstep Medical’s devices are listed in the FDA’s regulatory databases, specifically through the 510(k) premarket notification process and the Unique Device Identifier (UDI) system. These registries ensure transparency and traceability of medical devices, allowing healthcare providers, regulators, and patients to access critical information about the device’s authorisation status, design, and intended use.

Nexstep Medical’s devices, such as the All'InCath 035M PTA Balloon Dilatation Catheter, are classified as Class II under the FDA’s regulatory framework. This classification indicates that while the devices pose a moderate level of risk, they are not considered high-risk like Class III devices. As a result, they require premarket notification (510(k)) clearance to demonstrate substantial equivalence to a legally marketed predicate device, ensuring they meet safety and effectiveness standards before entering the market.